ScholarIQanswers from OpenAlex

Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity

PaperCitations, authors & open-access status

Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity have?

ScholarIQcitation count

Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity has 434 citations in the OpenAlex counts ScholarIQ stores.

When was Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity published?

ScholarIQyear

Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity has 2021 year in the ScholarIQ index.

What is the open-access status of Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity?

ScholarIQoa status

Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity has green oa status in the ScholarIQ index.

What is the DOI of Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity?

ScholarIQdoi

The DOI for Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity is on the source record.

What is the PMID of Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity?

ScholarIQpmid

The PMID for Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity is on the source record.

What is the OpenAlex record for Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity?

ScholarIQopenalex

The OpenAlex for Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial